Sign in
CompletedPhase 1

Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy

Key facts

Who runs it
Nova Southeastern University
Where
Fort Lauderdale, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 1
People taking part
40 people enrolled
Started
7 Sept 2021
Ended
1 Jul 2025
Type of study
Interventional
Treatments tested
  • Oxygen 100 % Gas for Inhalation
  • Hyperbaric Oxygen Therapy Chamber
Record updated
26 August 2025

Who can take part

Age
18 years to 70 years
Sex
Men only
Healthy volunteers
Cannot take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • A male U.S. Veteran, suffer from mild traumatic brain injury characterized by:; a confused or disoriented state which lasts less than 24 hours; loss of consciousness for up to 30 minutes; memory loss lasting less than 24 hours. In good health prior to mild traumatic brain injury

Who cannot take part

  • Use of medications that could affect immune function (e.g., steroids, immunosuppressants) (self-report)
  • Are scheduled for surgery during time of hyperbaric oxygen treatments; Contraindication for HBOT Therapy: untreated collapsed lung; Relative contraindications for HBOT Therapy: Includes pulmonary diseases including chronic obstructive lung disease, an air blister in the lung that appears on a chest radiograph but does not result in symptoms, upper respiratory or sinus infections, recent ear or thoracic surgery, uncontrolled fever, and claustrophobia. However, these are relative contraindications, which should not deter clinicians from using HBOT to treat patients with severe neurological injuries or other life or limb threatening conditions. The adverse effects of several medications are thought to be increased by HBOT, including bleomycin and doxorubicin. Other exclusions from participation includes pregnancy and participating in another interventional clinical trial of an investigational therapy within 30 days of consent or scheduled for surgery; Contraindication for brain SPECT scan: Known allergy to radioactive tracer material
  • Current treated or untreated major depression with psychotic or melancholic features, schizophrenia, bipolar disorder, delusional disorders, dementias of any type, and alcoholism or drug abuse
  • Current organ failure (as determined by self-report)
  • Current treated or untreated rheumatologic and inflammatory disorders, as determined by medical diagnosis of one or more of the following: osteoarthritis, rheumatoid arthritis, lupus erythematosus, spondyloarthropathies - ankylosing spondylitis and psoriatic arthritis, Sjogren's syndrome, gout, scleroderma, infectious arthritis, and polymyalgia rheumatica
  • Chronic active infections such as HIV, hepatitis B, and hepatitis C (self-report)
  • History of organ transplant (self-report)
  • Current primary sleep disorders such as insomnia, sleep related breathing disorders, etc; (self-report)
  • Any allergic disease (self-report) such as allergic asthma
  • Renal insufficiency
  • Hepatic insufficiency
  • Currently have no exclusionary diagnoses that could reasonably explain the symptoms of their fatiguing illness and their severity, using the exclusion criteria best described in case definition paper for Chronic Fatigue Syndrome (CFS), as described in detail in Reeves, et all 2003, which clarifies exclusionary conditions
  • History of moderate to severe traumatic brain injury or TBI requiring hospitalization in the past five years
  • An individual is ineligible to participate if does not meet the criteria for mild traumatic brain injury and if any of the following apply:
  • Female gender due to small pilot study and hormonal changes in women
  • Current heavy use of alcohol or tobacco use (self-report in last 6 months)
  • Unstable PTSD or PTSD requiring hospitalization in the past 5 years (stable PTSD is allowed) - this is to reduce the risk of a claustrophobic triggering of PTSD symptoms; (limits generalizability of results to mild/moderate stable PTSD)

Where in United States

  • Nova Southeastern UniversityFort Lauderdale, United States

About the trial

What the trial wants to find out

Mild traumatic brain (mTBI) injury affects 400,000 U.S. Veterans resulting in physical, cognitive and mental health symptoms. The Department of Defense (DoD) reported 26 suicides a day from mTBI despite ongoing care for the Veterans. The purpose of this pilot research study is to evaluate the effect of treating Veterans suffering from mTBI or persistent post-concussion syndrome with hyperbaric oxygen therapy (HBOT).

The group in the trial

  • Treatment of U.S. Veterans with mild traumatic brain injury with hyperbaric oxygen therapyOther group

    Pilot Study - A total of 40 HBOT treatments at 1.5 atmospheres absolute (ATA) for a dive time of 60 minutes, twice a day Monday through Friday. The treatments were separated by an air break of 4 hours on the same day. Measurements of the effectiveness of HBOT in mTBI done before and after HBOT.

    Treatment: Oxygen 100 % Gas for Inhalation and Hyperbaric Oxygen Therapy Chamber

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
26 August 2025